Hawktail Research
Investment Thesis
Hawktail is a San Francisco-based seed-stage venture capital firm that backs early-stage, transformational technology across life sciences, climate tech, deep tech, and software. Founded in 2021 by Michael Polansky, the firm has built one of the most prolific and eclectic seed portfolios in the market, spanning biotech platforms, carbon removal, aerospace, robotics, AI, and web3. Rather than concentrating in a single vertical, Hawktail positions itself as a generalist backer of scientifically or technically ambitious founders at the earliest, highest-risk stage, frequently investing in category-defining or category-creating companies well before consensus forms.
Sector Focus
Hawktail's own site organizes its portfolio under the tags Tech, Biotech, Productivity, Climate, Life Science, Food, Transportation, Finance, Sustainability, A.I., Social Impact, Energy, Data, Agriculture, Health, and Carbontech. In practice this spans:
- Biotech and life sciences platforms (cell and protein engineering, RNA therapeutics, immune-system research tools)
- Climate and carbon removal (direct air capture, ocean-based biomaterials, carbon accounting, decarbonized concrete)
- Deep tech and aerospace (reusable rockets, satellite and orbital infrastructure, deep-space communications, defense drones)
- Enterprise and developer software, often AI-native (legal tech, wealth management, laboratory software, internal-tools builders)
- Consumer and web3 (NFT membership platforms, creator economy tooling, decentralized messaging)
Stage Focus
Hawktail is explicitly a seed-stage investor (the site subtitles itself "Seed Stage VC"). Third-party trackers show 80+ cumulative investments with a steady cadence of new seed deals through 2026, indicating an actively deploying, high-volume seed strategy rather than concentrated, large-check investing.
Check Size and Lead Tendency
Public sources do not disclose a stated check-size range or fund size with confidence; a data aggregator's tracked-capital figure (~$28M) likely understates true fund size given the breadth of the portfolio, so it is treated as unreliable and omitted here. Hawktail appears frequently as a syndicate participant alongside other institutional seed and early-stage investors (e.g., Wing Venture Capital, Initialized Capital, and Sozo Ventures co-invested with Hawktail in Outer Bio's 2026 seed round), suggesting the firm often participates in rounds led by other funds rather than exclusively leading.
Recent Activity
Hawktail has remained active through 2026, with recent seed investments including Outer Bio (AI-driven skin research platform co-founded by Hawktail's own Michael Polansky, raised ~$23M seed in August 2026), General Legal (AI-native law firm, $11.5M seed in March 2026), and Leaked Labs (beauty formulas, seed in Q1 2026). The firm's pace of roughly half a dozen or more new investments per year across the trailing 12 months indicates an actively deploying posture.
Portfolio Highlights
Hawktail's portfolio includes notable names such as bit.bio (cell programming), STOKE Space and Outpost (space infrastructure), Cascade Space (deep-space comms), Heirloom Carbon (direct air capture), NCX (carbon markets), Meatable (cultivated meat), Cellino (cell manufacturing automation), Seaport Therapeutics (neuropsychiatric medicines), and District/CreatorDAO and Highlight.xyz (web3 creator tooling). Several portfolio companies are building in frontier categories (space, synthetic biology, carbon removal) well ahead of broader VC consensus.
Team
- Michael Polansky, Founder: Founded Hawktail in 2021; also founder of portfolio company Outer Bio, an AI-driven skin biotech.
- Robert Pollak, Managing Partner: Managing Member of the Hawktail funds since 2021 per SEC Form ADV filings.
- Alda Leu Dennis, Managing Partner: Joined Hawktail in January 2024; previously an active early-stage investor who led investments in Coupang, Planet, and CourseHero.
Decision Process
With three named partners across the fund's Form ADV filings, Hawktail appears to operate as a small partnership rather than a solo-GP shop, though the site gives no detail on formal decision process or timeline.
Founder Preferences
The portfolio skews toward founders tackling deep technical or scientific risk — biotech platform builders, aerospace engineers, climate hard-tech founders — alongside a smaller cohort of AI-native software founders, suggesting a preference for technical, mission-driven teams willing to work on long-horizon, high-uncertainty problems.
Geographic Focus
Based in San Francisco/Bay Area; the portfolio is overwhelmingly US-based with no strong evidence of a specific non-US geographic focus.